Balyasny Asset Management
MRK icon

Balyasny Asset Management’s Merck MRK Stock Holding History

Balyasny Asset Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.2M Sell
110,100
-124,600
-53% -$14.4M 0.02% 883
2025
Q4 		$24.7M Buy
234,700
+189,300
+417% +$17.8M 0.03% 614
2025
Q3 		$3.81M Sell
45,400
-9,300
-17% -$766K ﹤0.01% 1501
2025
Q2 		$4.33M Sell
54,700
-64,700
-54% -$5.14M 0.01% 1360
2025
Q1 		$10.7M Buy
119,400
+88,200
+283% +$8.23M 0.02% 878
2024
Q4 		$3.1M Buy
31,200
+800
+3% +$82.5K ﹤0.01% 1493
2024
Q3 		$3.45M Sell
30,400
-5,500
-15% -$653K 0.01% 1430
2024
Q2 		$4.44M Buy
35,900
+3,200
+10% +$412K 0.01% 1224
2024
Q1 		$4.31M Sell
32,700
-11,500
-26% -$1.42M 0.01% 1281
2023
Q4 		$4.82M Buy
44,200
+12,800
+41% +$1.33M 0.01% 1125
2023
Q3 		$3.23M Buy
+31,400
New +$3.38M 0.01% 1250
2023
Q1 		– Sell
-18,400
Closed -$2.04M – 2968
2022
Q4 		$2.04M Sell
18,400
-109,600
-86% -$11.2M 0.01% 1407
2022
Q3 		$11M Sell
128,000
-321,900
-72% -$28.7M 0.03% 646
2022
Q2 		$41M Buy
449,900
+397,300
+755% +$35.2M 0.13% 197
2022
Q1 		$4.32M Buy
+52,600
New +$4.15M 0.01% 1016
2021
Q3 		– Sell
-11,000
Closed -$855K – 2255
2021
Q2 		$855K Buy
+11,000
New +$818K ﹤0.01% 1361
2019
Q4 		– Sell
-157,200
Closed -$12.6M – 1363
2019
Q3 		$12.6M Buy
+157,200
New +$12.6M 0.09% 341
2019
Q2 		– Sell
-104,800
Closed -$8.32M – 1640
2019
Q1 		$8.32M Buy
+104,800
New +$7.84M 0.06% 434

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Balyasny Asset Management's MRK Position: Q1 2026 in Review

Balyasny Asset Management reduced its Merck (MRK) stake by 17% in Q1 2026, selling an estimated $43.3M and leaving 1,812,608 shares worth $218M. The position accounts for 0.28% of the portfolio, ranked #53.

Balyasny Asset Management first reported a position in MRK in Q3 2013 and has held it in 43 quarters since. The position peaked at $230M in Q4 2025. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Balyasny Asset Management held 1,812,608 shares of Merck worth $218M as of Q1 2026.
  • Balyasny Asset Management sold 374,652 Merck shares in Q1 2026, an estimated $43.3M.
  • Merck made up 0.28% of Balyasny Asset Management's portfolio in Q1 2026, its #53 holding.
  • Balyasny Asset Management first reported a position in Merck in Q3 2013 and has held it in 43 quarters since.
  • Balyasny Asset Management's Merck position peaked at $230M in Q4 2025.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.